Ixensor Co Documenti
Documenti
0
Ticker
6734.TWO
ISIN
TW0006734007
Ixensor Co SEC Filings
Tipo | Rapporto | Data |
|---|---|---|
| Nessun documento disponibile | ||
Ixensor Co Documenti 2026
Questa pagina contiene tutti i documenti ufficiali e i filing SEC dell'azione Ixensor Co (6734.TWO, ISIN: TW0006734007). Sono incluse le relazioni annuali (Form 10-K), le relazioni trimestrali (Form 10-Q) e le transazioni degli insider (Form 4). Attualmente sono disponibili 0 documenti. I dati vengono aggiornati regolarmente per offrire agli investitori una panoramica completa dei depositi regolamentari di Ixensor Co.
Ixensor Co Analisi delle Azioni
Ixensor Co iXensor Co., Ltd. generates revenue through its PixoTest Blood Glucose Monitoring System and ovulation detection system, targeting individuals managing diabetes and reproductive health. The company's technology platform measures biochemical parameters including blood sugar, luteinizing hormone, and cholesterol, providing data for diabetes management services. Its integrated medical device solutions serve customers seeking self-monitoring tools for chronic conditions and fertility tracking. The firm's products are designed for direct consumer use, with the PixoTest system offering blood glucose monitoring and the ovulation detection system supporting female hormone cycle management. These solutions leverage the company's platform to deliver personalized health insights without requiring third-party partnerships. The target segments include patients with diabetes and individuals tracking fertility cycles through biochemical monitoring.